When Is It Appropriate to Use Glutamine in Critical Illness? - Wikidata - awgldk - TriplyDB

When Is It Appropriate to Use Glutamine in Critical Illness?

When Is It Appropriate to Use Glutamine in Critical Illness?

http://www.wikidata.org/entity/Q38849482

about

Therapeutic benefits of glutamine: An umbrella review of meta-analyses.

P2860

Q33685522-FB086C1B-C4CE-4550-8050-32B8AAFE77CD

P2860

When Is It Appropriate to Use Glutamine in Critical Illness?

http://www.wikidata.org/entity/Q38849482

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

When Is It Appropriate to Use Glutamine in Critical Illness?

@en

type

label

When Is It Appropriate to Use Glutamine in Critical Illness?

@en

prefLabel

When Is It Appropriate to Use Glutamine in Critical Illness?

@en

P1433

Q38849482-40C42A5C-9B1C-4D43-B339-91368996599E

P1476

Q38849482-DE747C8A-C6A7-4609-9213-D6D44D6176D8

P2093

Q38849482-94C145B0-D024-4A5A-BF2D-F49A94F623D0

Q38849482-AA8DB15D-0121-45D5-B452-E6CF24E2793B

Q38849482-B4AE21DA-4974-4099-AF21-C63F0E78E199

P2860

Q38849482-041B93F5-9BD8-4160-96EC-0CF79A503F08

Q38849482-04424B0B-B4DC-45C8-B200-3E72A6F3E410

Q38849482-054CAC80-82A6-4C07-A383-3ABD819CD7EA

Q38849482-09F08097-CCA9-4435-92FB-95C83280D1C8

Q38849482-0AA3AD73-46FE-4B46-9162-BC8A347C5CC5

Q38849482-0B43C82D-9F6B-44A9-A5A2-4790AA1AF186

Q38849482-0D139DB9-2A26-4039-BB76-D671F285750E

Q38849482-15789712-44E2-424C-A3B4-EACB19EB96C0

Q38849482-1FC8D9CE-E6FC-4EA7-ABD3-53051BAAF851

Q38849482-27566A4B-56CA-45C8-BAE3-A3086C6AC0CA

P304

Q38849482-D51CA027-079B-405A-8B85-9E648B722522

P31

Q38849482-86BA30F7-6AE3-4ED8-BC12-D9E10AA18C1B

P356

Q38849482-A0F28864-A5A0-45FD-BFA4-CD057348CA9B

P433

Q38849482-9347A9EE-C13A-41F9-A510-01A1C961E715

P478

Q38849482-7CE105A5-6815-4B2E-8529-539B6B3C92BF

P577

Q38849482-C6B87823-F59C-4F42-93ED-2BF948C8D331

P698

Q38849482-190679DA-A159-4A07-8E61-92B7C790004B

P356

0884533616651318

P1433

Nutrition in Clinical Practice

P1476

When Is It Appropriate to Use Glutamine in Critical Illness?

@en

P2093

Manpreet S Mundi

http://www.w3.org/2001/XMLSchema#string

Meera Shah

http://www.w3.org/2001/XMLSchema#string

Ryan T Hurt

http://www.w3.org/2001/XMLSchema#string

P2860

The effect of glutamine intake on complications of colorectal and colon cancer treatment: A systematic review

Enteral glutamine supplementation in critically ill patients: a systematic review and meta-analysis

Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial

Total parenteral nutrition with glutamine dipeptide after major abdominal surgery: a randomized, double-blind, controlled study

Differential induction of PPAR-gamma by luminal glutamine and iNOS by luminal arginine in the rodent postischemic small bowel

Lymphocyte glucose and glutamine metabolism as targets of the anti-inflammatory and immunomodulatory effects of exercise.

A meta-analysis of trials using the intention to treat principle for glutamine supplementation in critically ill patients with burn.

Protection by enteral glutamine is mediated by intestinal epithelial cell peroxisome proliferator-activated receptor-γ during intestinal ischemia/reperfusion.

Glutamine and glutathione at ICU admission in relation to outcome.

The role of glutamine in intensive care unit patients: mechanisms of action and clinical outcome.

P304

445-450

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0884533616651318

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27246308

http://www.w3.org/2001/XMLSchema#string